Paroxysmal dyskinesias with drowsiness and thalamic lesions in GABA transaminase deficiency
Authors:
- Hugo Morales-BriceñoHMHugo Morales-Briceño
- Florence C.F. ChangFCFlorence C.F. Chang
- Chong WongCWChong Wong
- Amali MallawaarachchiAMAmali Mallawaarachchi
- Nigel WolfeNWNigel Wolfe
- Renata Pellegrino da SilvaRSRenata Pellegrino da Silva
- Hakon HakonarsonHHHakon Hakonarson
- Sarah Annabella SandaraduraSSSarah Annabella Sandaradura
- Yiran GuoYGYiran Guo
- John ChristodoulouJCJohn Christodoulou
- Jim LagopoulosJLJim Lagopoulos
- Padraic Grattan-SmithPGPadraic Grattan-Smith
- 8 January 2019
- journal article
- editorial
- Published by Wolters Kluwer Health in Neurology
- Vol. 92 (2) , 94-97
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Metabolomics Profile in ABAT Deficiency Pre- and Post-treatment2018
- Serial Magnetic Resonance Imaging and 1H-Magnetic Resonance Spectroscopy in GABA Transaminase Deficiency: A Case Report2018
- Phenotype of GABA-transaminase deficiencyNeurology, 2017
- The GABA Transaminase, ABAT, Is Essential for Mitochondrial Nucleoside MetabolismCell Metabolism, 2015
- Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?European Journal of Paediatric Neurology, 2012
- A new case of GABA transaminase deficiency facilitated by proton MR spectroscopyJournal of Inherited Metabolic Disease, 2010
- Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiencyNeurology, 2007